• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞周期蛋白依赖性激酶抑制剂p27及其在乳腺癌中的预后作用。

The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer.

作者信息

Chiarle R, Pagano M, Inghirami G

机构信息

Department of Pathology, New York University School of Medicine, New York, USA.

出版信息

Breast Cancer Res. 2001;3(2):91-4. doi: 10.1186/bcr277. Epub 2000 Dec 20.

DOI:10.1186/bcr277
PMID:11250752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC139437/
Abstract

p27 is an inhibitor of cyclin dependent kinase involved in the regulation of the cell cycle. In this commentary we discuss the current knowledge on p27 in breast cancer and its significance in predicting the outcome. p27 protein levels are high in most cases of breast carcinomas, are correlated with the levels of cyclin D1 and estrogen receptor, and could be a useful predictor of survival, because they are low in aggressive carcinomas. Immunodetection of p27 in breast tumors could be useful in the assessment of prognosis, especially in those cases in which the commonly used parameters are insufficient, and might ultimately influence the therapy of this disease.

摘要

p27是一种参与细胞周期调控的细胞周期蛋白依赖性激酶抑制剂。在本评论中,我们讨论了目前关于p27在乳腺癌中的知识及其在预测预后方面的意义。在大多数乳腺癌病例中,p27蛋白水平较高,与细胞周期蛋白D1和雌激素受体水平相关,并且可能是生存的有用预测指标,因为在侵袭性癌中其水平较低。乳腺肿瘤中p27的免疫检测在预后评估中可能有用,特别是在那些常用参数不足的病例中,并且最终可能会影响这种疾病的治疗。

相似文献

1
The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer.细胞周期蛋白依赖性激酶抑制剂p27及其在乳腺癌中的预后作用。
Breast Cancer Res. 2001;3(2):91-4. doi: 10.1186/bcr277. Epub 2000 Dec 20.
2
Prognostic impact of cyclin-dependent kinase inhibitor p27kip1 in node-positive breast cancer.
J Surg Oncol. 1999 Apr;70(4):230-4. doi: 10.1002/(sici)1096-9098(199904)70:4<230::aid-jso6>3.0.co;2-i.
3
Cyclin-dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma.细胞周期蛋白依赖性激酶抑制剂p27Kip1在乳腺癌中的表达及其与其他细胞周期相关蛋白的相互作用
J Pathol. 1999 Jan;187(2):200-6. doi: 10.1002/(SICI)1096-9896(199901)187:2<200::AID-PATH228>3.0.CO;2-M.
4
Prognostic value of p27(Kip1) and CyclinD1 expression in esophageal cancer.
Oncology. 1999 Nov;57(4):311-7. doi: 10.1159/000012067.
5
p27 expression as a prognostic factor of breast cancer in Taiwan.p27表达作为台湾地区乳腺癌的一个预后因素。
Cancer Lett. 1999 Jul 1;141(1-2):123-30. doi: 10.1016/s0304-3835(99)00084-1.
6
p27 Expression, a cyclin dependent kinase inhibitor in breast carcinoma.p27表达,一种乳腺癌中的细胞周期蛋白依赖性激酶抑制剂。
Adv Clin Path. 1999 Oct;3(4):119-27.
7
The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas.细胞周期抑制剂p27是小(T1a、b)浸润性乳腺癌的独立预后标志物。
Cancer Res. 1997 Apr 1;57(7):1259-63.
8
p21, p27, cyclin D1, and p53 in rectal cancer: immunohistology with prognostic significance?直肠癌中的p21、p27、细胞周期蛋白D1和p53:具有预后意义的免疫组织化学?
Int J Colorectal Dis. 2002 Jan;17(1):11-9. doi: 10.1007/s003840100333.
9
Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter.p27Kip1和Ki-67表达在肾盂和输尿管癌中的预后意义
BJU Int. 2000 Jul;86(1):14-9. doi: 10.1046/j.1464-410x.2000.00726.x.
10
High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers.p27(kip1)和细胞周期蛋白D1在某些人类乳腺癌细胞中的高表达:p27(kip1)的表达与人类乳腺癌和结直肠癌恶性程度之间的负相关。
Proc Natl Acad Sci U S A. 1997 Jun 10;94(12):6380-5. doi: 10.1073/pnas.94.12.6380.

引用本文的文献

1
MicroRNA-494 augments fibrotic transformation of human retinal pigment epithelial cells and targets p27 with cell-type specificity.微小RNA-494增强人视网膜色素上皮细胞的纤维化转化并以细胞类型特异性靶向p27。
Front Ophthalmol (Lausanne). 2023 Apr 14;3:1168650. doi: 10.3389/fopht.2023.1168650. eCollection 2023.
2
From Diabetes to Oncology: Glucagon-like Peptide-1 (GLP-1) Receptor Agonist's Dual Role in Prostate Cancer.从糖尿病到肿瘤学:胰高血糖素样肽-1(GLP-1)受体激动剂在前列腺癌中的双重作用
Cancers (Basel). 2024 Apr 18;16(8):1538. doi: 10.3390/cancers16081538.
3
Integrative analysis identifies two molecular and clinical subsets in Luminal B breast cancer.综合分析确定了管腔B型乳腺癌的两个分子和临床亚组。
iScience. 2023 Jul 26;26(9):107466. doi: 10.1016/j.isci.2023.107466. eCollection 2023 Sep 15.
4
Janus Kinase 3 phosphorylation and the JAK/STAT pathway are positively modulated by follicle-stimulating hormone (FSH) in bovine granulosa cells.Janus 激酶 3 磷酸化和 JAK/STAT 通路在牛颗粒细胞中受到卵泡刺激素 (FSH) 的正向调节。
BMC Mol Cell Biol. 2023 Jun 20;24(1):21. doi: 10.1186/s12860-023-00482-5.
5
ACKnowledging the role of the Activated-Cdc42 associated kinase (ACK) in regulating protein stability in cancer.承认激活的 Cdc42 相关激酶 (ACK) 在调节癌症中蛋白质稳定性的作用。
Small GTPases. 2023 Dec;14(1):14-25. doi: 10.1080/21541248.2023.2212573.
6
A gene signature consisting of ubiquitin ligases and deubiquitinating enzymes of SKP2 is associated with clinical outcome in breast cancer.由 SKP2 的泛素连接酶和去泛素化酶组成的基因特征与乳腺癌的临床结局相关。
Sci Rep. 2022 Feb 15;12(1):2478. doi: 10.1038/s41598-022-06451-w.
7
A prospective phase II clinical trial identifying the optimal regimen for carboplatin plus standard backbone of anthracycline and taxane-based chemotherapy in triple negative breast cancer.一项前瞻性II期临床试验,旨在确定卡铂联合蒽环类和紫杉类化疗标准主干方案用于三阴性乳腺癌的最佳方案。
Med Oncol. 2022 Feb 1;39(4):49. doi: 10.1007/s12032-021-01637-0.
8
Synthesis of Novel 2-Thiouracil-5-Sulfonamide Derivatives as Potent Inducers of Cell Cycle Arrest and CDK2A Inhibition Supported by Molecular Docking.新型 2-硫代尿嘧啶-5-磺胺衍生物的合成及其作为细胞周期阻滞和 CDK2A 抑制剂的潜力:基于分子对接的研究。
Int J Mol Sci. 2021 Nov 4;22(21):11957. doi: 10.3390/ijms222111957.
9
Overcoming tamoxifen resistance in oestrogen receptor-positive breast cancer using the novel thiosemicarbazone anti-cancer agent, DpC.使用新型噻唑烷酮类抗癌剂 DpC 克服雌激素受体阳性乳腺癌的耐药性。
Br J Pharmacol. 2020 May;177(10):2365-2380. doi: 10.1111/bph.14985. Epub 2020 Feb 12.
10
Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation.双酚A通过激活EGFR/ERK/p53信号通路诱导原代细胞和前列腺癌细胞发生细胞周期阻滞。
Oncotarget. 2017 Dec 18;8(70):115620-115631. doi: 10.18632/oncotarget.23360. eCollection 2017 Dec 29.

本文引用的文献

1
The F-box protein family.F-box蛋白家族。
Genome Biol. 2000;1(5):REVIEWS3002. doi: 10.1186/gb-2000-1-5-reviews3002. Epub 2000 Nov 10.
2
A comparison of cell cycle markers in well-differentiated lobular and ductal carcinomas.高分化小叶癌和导管癌中细胞周期标志物的比较。
Breast Cancer Res Treat. 2000 May;61(2):161-70. doi: 10.1023/a:1006479113769.
3
Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells.p21WAF1/CIP1或p27Kip1的下调可消除抗雌激素介导的人乳腺癌细胞的细胞周期停滞。
Proc Natl Acad Sci U S A. 2000 Aug 1;97(16):9042-6. doi: 10.1073/pnas.160016897.
4
p27(kip1) expression in breast carcinomas: an immunohistochemical study on 512 patients with long-term follow-up.乳腺癌中p27(kip1)的表达:对512例患者进行长期随访的免疫组织化学研究
Int J Cancer. 2000 May 20;89(3):236-41.
5
ErbB2 potentiates breast tumor proliferation through modulation of p27(Kip1)-Cdk2 complex formation: receptor overexpression does not determine growth dependency.ErbB2通过调节p27(Kip1)-Cdk2复合物的形成增强乳腺肿瘤增殖:受体过表达并不决定生长依赖性。
Mol Cell Biol. 2000 May;20(9):3210-23. doi: 10.1128/MCB.20.9.3210-3223.2000.
6
Cell cycle proteins do not predict outcome in grade I infiltrating ductal carcinoma of the breast.细胞周期蛋白不能预测乳腺I级浸润性导管癌的预后。
Int J Cancer. 2000 Jan 20;89(1):26-31. doi: 10.1002/(sici)1097-0215(20000120)89:1<26::aid-ijc5>3.0.co;2-8.
7
Immunohistochemical analysis of Ki-67, p53, p21, and p27 in benign and malignant apocrine lesions of the breast: its correlation to histologic findings in 43 cases.乳腺良性和恶性大汗腺病变中Ki-67、p53、p21和p27的免疫组织化学分析:43例病例与组织学结果的相关性
Mod Pathol. 2000 Jan;13(1):13-8. doi: 10.1038/modpathol.3880004.
8
Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.细胞周期蛋白依赖性激酶抑制剂p27的蛋白酶体降解增加与套细胞淋巴瘤的总生存期缩短有关。
Blood. 2000 Jan 15;95(2):619-26.
9
p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells.p45SKP2促进p27Kip1降解并诱导静止细胞进入S期。
Nat Cell Biol. 1999 Aug;1(4):207-14. doi: 10.1038/12027.
10
SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27.SKP2是泛素介导的细胞周期蛋白依赖性激酶抑制剂p27降解所必需的。
Nat Cell Biol. 1999 Aug;1(4):193-9. doi: 10.1038/12013.